Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Acorda Therapeutics, Inc. (ACOR)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 1.7 | 1.2 | 1.3 | 2.9 | 2.8 | 2.7 | 2.9 | 3.1 |
| Asset turnover | 0.2 | 0.2 | 0.2 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -92.2% | -37.7% | -97.8% | 226.5% | 252.2% | -15.9% | 12.0% | 8.9% |
| ROIC (including intangibles) | -19.5% | -14.5% | -31.6% | 27.8% | 12.2% | -2.2% | 2.9% | 3.5% |
| ROE | -35.5% | -23.4% | -48.6% | 30.7% | 14.1% | -3.1% | 3.8% | 4.6% |
| ROA | -15.3% | -11.4% | -25.9% | 18.8% | 7.8% | -1.7% | 2.3% | 2.6% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 48.1 | 48.2 | 41.9 | 18.1 | 50.5 | 36.7 | 23.3 | 29.3 |
| Days payables outstanding | 97.1 | 132.4 | 275.0 | 182.6 | 89.7 | 91.5 | 56.3 | 81.0 |
| Days inventory outstanding | 166.0 | 312.3 | 264.2 | 108.5 | 123.0 | 146.5 | 144.2 | 119.8 |
| Cash conversion cycle | 117.0 | 228.1 | 31.0 | -56.0 | 83.7 | 91.7 | 111.3 | 68.1 |
|